Jacob Ballas Capital India
Jacob Ballas, NYLIM to invest in India's Centrum Capital
Jacob Ballas and New York Life Investment Management (NYLIM) will invest in CentrumDirect, the foreign exchange business of India-listed financial services company Centrum Capital.
Fortis healthcare raises $100m from IFC
Indian hospital and diagnostics group Fortis Healthcare is to issue 28.6 million shares to the International Finance Corporation (IFC) for a total of $45 million. Another $55 million will come through a private placement of foreign currency convertible...
Jacob Ballas supports Indian diagnostics chain
The $40 billion Indian healthcare market is growing rapidly and has seen numerous PE investments into hospital chains and pharmaceutical companies. However, the country’s diagnostic expertise and infrastructure still lag behind.
Fortis raises $66m from Jacob Ballas, IFC for Super Religare
Bangalore-based Fortis Healthcare has reached agreements with Jacob Ballas Capital and the International Finance Corporation (IFC) to raise INR3.7 billion ($66.4 million) for its diagnostics unit Super Religare Laboratories (SRL).
Jacob Ballas injects $38m in Marg Karaikal Port
Private equity firm Jacob Ballas Capital has provided Marg Karaikal Port, a unit of infrastructure and real estate company MARG, with a $38 million cash boost.
PE firms to invest in Super Religare Laboratories
Super Religare Laboratories (SRL), a pathology laboratory network in India, is likely to receive commitments from two private equity firms for its 15-20% stake sale.
Jacob Ballas commits $20m to Indian engineering company
Jacob Ballas Capital India has aggreed to pay INR1 billion ($20.29 million) for a minority stake in DBM Geotechnics and Constructions, an Indian engineering infrastructure firm.
Jacob Ballas pumps $38m into Religare Finvest
Jacob Ballas Capital India has given Religare Finvest, the non-banking arm of Indian financial services group Religare Enterprises, a INR2 billion ($37.5 million) cash injection.
Jacob Ballas plans to invest $150m into India next year
Managing director of India-focused Jacob Ballas Capital, Srinivas Chidambaram, confirmed to media that the firm plans to invest $150 million into the Indian market within the next year.
Indian tech VC: Where’s the exit?
MakeMyTrip’s stellar IPO on NASDAQ last year has a host of other companies preparing to follow suit. The implications for VC are unclear
Indian drug maker Vivimed gets $25.8m from private equity
NYLIM Jacob Ballas India Fund and Kitara Capital have committed INR1.27 billion ($25.8 million) to Indian pharmaceutical firm Vivimed Labs.
Evolvence, Jacob Ballas, NYLIM pick up Emaar MGF pre-IPO shares
Emaar MGF, the Indian real estate development company set up jointly by Dubai's Emaar Properties and northern Indian retail real estate developer MGF Development, has sold stakes to existing shareholders Evolvence India Holdings, Jacob Ballas and New...
Private equity-backed Gujarat Pipavav Port makes strong debut onto Indian stock exchange
Gujarat Pipavav Port Ltd., a container terminal backed by PE firms including IDFC, made a strong debut on India's National Stock Exchange, trading at a 22% premium at INR56.1 ($1.21) from its INR46 ($.99) issue price.
Jacob Ballas invests SEW Infrastructure
Indian private equity investor NYLIM Jacob Ballas has made a $34 million investment into SEW Infrastructure, a Hyderabad-headquartered engineering and construction company specializing in hydroelectric power, irrigation, roads and urban infrastructure.
Jacob Ballas, NEA, team on FSS deal
Jacob Ballas Capital India and US VC major New Enterprise Associates have reportedly teamed up to invest $60 million in Chennai-based electronic payments player Financial Software & Systems Ltd., for around 40% of the company.